Biosimilar G-CSF based mobilization of peripheral blood hematopoietic stem cells for autologous and allogeneic stem cell transplantation
about
Mobilization, Isolation and Characterization of Stem Cells from Peripheral Blood: a Systematic ReviewUse of biosimilar filgrastim compared with lenograstim in autologous haematopoietic stem-cell transplant and in sibling allogeneic transplant.Safety and efficacy of granulocyte colony-stimulating factor biosimilars in engraftment after autologous stem cell transplantation for haematological malignancies: a 4-year, single institute experience with different conditioning regimensAging Effects on Cardiac Progenitor Cell Physiology.Biosimilar G-CSF versus filgrastim and lenograstim in healthy unrelated volunteer hematopoietic stem cell donors.Tbo-Filgrastim: A Review in Neutropenic Conditions.Evaluation of a biosimilar granulocyte colony-stimulating factor (filgrastim XM02) for peripheral blood stem cell mobilization and transplantation: a single center experience in Japan.Mobilization of autologous and allogeneic peripheral blood stem cells for transplantation in haematological malignancies using biosimilar G-CSF.Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patients.Filgrastim versus TBO-filgrastim to reduce the duration of neutropenia after autologous hematopoietic stem cell transplantation: TBO, or not TBO, that is the question.Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation.Biosimilar granulocyte-colony-stimulating factor for mobilization of autologous peripheral blood stem cells in pediatric hematology-oncology patients.Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study.Extrapolation concept at work with biosimilar: a decade of experience in oncology.
P2860
Q33652381-3718D461-46DE-4764-A05A-9829D082D671Q35192785-4376D3C4-19E1-4E12-8AC7-5C9FCEE14A0CQ36187379-FFCE7B88-6A7F-462D-AF03-3E7754569350Q38596695-A78AED34-FE1C-44EC-845F-BD70E3EA7221Q38628058-2A9B3B83-A2FA-45AE-B010-920D3010A12EQ38792513-710EE367-95F7-4C51-B55B-92DFAE65CDD3Q38969947-23966AC0-A630-4FD7-95C5-E15A16C1C47FQ39504419-478CC8BA-897E-4298-AFE4-D9077CF42388Q39900044-BDF7DB46-0641-4D5C-A6E8-78145D22493EQ40402240-17BF77F7-3372-4461-9AFD-76ECA41CE178Q40561903-648F845E-9A1A-4A24-93D6-1B730612D31AQ46922809-10B63EF4-0052-441F-9E1A-CAEB78A73054Q54652394-3C789421-C8ED-4CB5-ACF5-A14E4883F1A6Q55384042-30662FC2-3F91-4852-ACBD-A1FFDEFE8BAA
P2860
Biosimilar G-CSF based mobilization of peripheral blood hematopoietic stem cells for autologous and allogeneic stem cell transplantation
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biosimilar G-CSF based mobiliz ...... neic stem cell transplantation
@en
type
label
Biosimilar G-CSF based mobiliz ...... neic stem cell transplantation
@en
prefLabel
Biosimilar G-CSF based mobiliz ...... neic stem cell transplantation
@en
P2093
P2860
P356
P1433
P1476
Biosimilar G-CSF based mobiliz ...... neic stem cell transplantation
@en
P2093
Amy Publicover
Anita Schmitt
Arnon Nagler
Matthias Görlach
Michael Schmitt
Reeba Kuriakose
P2860
P304
P356
10.7150/THNO.7752
P577
2014-01-23T00:00:00Z